Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
This bill prohibits any Federal department, agency, or office from conducting, funding, approving, or otherwise supporting research that uses human fetal tissue obtained pursuant to an induced abortion. It allows research on fetal tissue obtained after a miscarriage or stillbirth and permits development of new, non-abortion-derived high-efficiency cell lines.
Progressives stress research and public-health harms; conservatives stress ethical protection.
Relative to its intended legislative type, this bill is a clearly focused substantive policy change that is implemented through direct amendments to existing statutory provisions.
This bill prohibits any Federal department, agency, or office from conducting, funding, approving, or otherwise supporting research that uses human fetal tissue obtained pursuant to an induced abortion.
It allows research on fetal tissue obtained after a miscarriage or stillbirth and permits development of new, non-abortion-derived high-efficiency cell lines.
The bill amends provisions of the Public Health Service Act to limit federally supported fetal tissue research to miscarriage or stillbirth sources, repeals a prior NIH provision, and bars solicitation or knowing acquisition of donations of fetal tissue obtained from induced abortions.
A high-salience abortion-related restriction on federal research faces strong institutional and stakeholder resistance; low odds without wide bipartisan support or tradeoffs.
Relative to its intended legislative type, this bill is a clearly focused substantive policy change that is implemented through direct amendments to existing statutory provisions. It specifies prohibitions, definitions, and narrow exceptions, and it integrates with named sections of the Public Health Service Act.
Progressives stress research and public-health harms; conservatives stress ethical protection.
These are examples from the analysis, not a ranked list of the most-affected groups.
Progressives stress research and public-health harms; conservatives stress ethical protection.
Likely to oppose the bill because it restricts federally supported biomedical research using tissue from induced abortions.
They will worry about negative effects on basic research, translational studies, and public-health projects, and see the ban as ideologically driven more than evidence-based.
Mixed view: recognizes ethical aims of restricting abortion-derived tissue use but worries about scientific and implementation consequences.
Supports clearer safeguards, but would seek narrow, well-defined exceptions and transition funding for alternatives.
Likely to strongly support the bill as preventing federal involvement in research using tissue from induced abortions.
Views it as upholding pro-life ethics, removing incentives, and aligning federal funds with moral priorities.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
A high-salience abortion-related restriction on federal research faces strong institutional and stakeholder resistance; low odds without wide bipartisan support or tradeoffs.
The bill has not accumulated any surfaced votes yet.
Progressives stress research and public-health harms; conservatives stress ethical protection.
A high-salience abortion-related restriction on federal research faces strong institutional and stakeholder resistance; low odds without wi…
Relative to its intended legislative type, this bill is a clearly focused substantive policy change that is implemented through direct amendments to existing statutory provisions. It specifies prohibitions, definitions,…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.